/PRNewswire/ GOL Linhas Aéreas Inteligentes S.A. (NYSE: GOL and B3: GOLL4), ("GOL" or "Company"), Brazil s largest airline, today provides its Investor.
GLA Merger with Smiles Approved; Company Prepares for Demand Acceleration in 2Q21
Shareholders of GOL and Smiles approve corporate reorganization, that will provide significant operational and financial synergies, and enhance the Group s competitiveness;
Strong discipline in capacity management maintains profitability of operations;
Neutral cash consumption in March amid the cooling demand for air transport in Brazil, combined with the transition to the low season.
News provided by
Share this article
SÃO PAULO, April 29, 2021 /PRNewswire/
GOL Linhas Aéreas Inteligentes S.A. ( GOL or Company ) (NYSE: GOL and B3: GOLL4), Brazil s largest domestic airline, today announced its consolidated results for the first quarter of 2021 (1Q21), also outlining its continued initiatives in response to the Covid-19 pandemic.
Friday, 10:04, 16/04/2021
VOV.VN - During the initial novel coronavirus (COVID-19) vaccination drive, Vietnam has yet to record any cases of blood clots or thrombosis occurring after injection, according to the Ministry of Health.
Following over a month of efforts to begin inoculating the local population, the nation has carried out the process by using the AstraZeneca vaccine. This has seen more than 70,000 people, the majority of whom are frontline medical workers and members of community-based steering committees for COVID-19 prevention and control in 19 cities and provinces, vaccinated to ensure maximum safety.
Prof. Dr. Dang Duc Anh, director of the National Institute of Hygiene and Epidemiology, states that the immunisation procedures taking place locally are being implemented at the highest safety level, whilst differing from other countries in the world, including developed nations.
• hiperlinks dos quais o usuário utilizou para chegar em nossa página
1.6. Sempre que o USUÁRIO visitar ou interagir com os sites, a CÂMARA DE COMÉRCIO ÁRABE BRASILEIRA – CCAB pode usar uma variedade de tecnologias que coletam, automática ou passivamente, as informações sobre a forma como os sites são acessados.
1.7. Todas as tecnologias referidas e utilizadas no nosso ambiente digital de relacionamento respeitarão a legislação vigente e os termos desta política.
1.8. Ao navegar na nossa interface, o USUÁRIO poderá ser conduzido via link, conteúdo ou serviços, a outros portais ou plataformas que poderão coletar suas informações e ter sua própria Política de Privacidade. Portanto, caberá ao USUÁRIO manter-se atualizado destas políticas, cabendo a ele aceitá-las ou recusá-las. Não somos responsáveis pela Política de Privacidade nem pelo conteúdo de quaisquer websites, conteúdo ou serviços ligados ao portal, inclusive por meio de links.
Listen to the story.
São Paulo Governor João Doria points to a container carrying the experimental COVID-19 vaccine CoronaVac during a photo opportunity, after it was unloaded from a cargo plane that arrived from China at Guarulhos International Airport near São Paulo, Brazil, Nov. 19, 2020. Credit:
Share
As the number of COVID-19 fatalities keeps climbing, debate over the safety and effectiveness of coronavirus vaccines for use in Brazil is turning into a partisan tug of war.
CoronaVac, a vaccine developed by China’s Sinovac Biotech, has shown promising results. But scientists like Natalia Pasternak, a research fellow at the University of São Paulo’s Institute of Biomedical Sciences says Brazil’s President Jair Bolsonaro is attempting to block use of the vaccine simply because it was developed in China.